Gammoh, O.; Qnais, E.Y.; Athamneh, R.Y.; Al-Jaidi, B.; Al-Tawalbeh, D.; Altaber, S.; Alqudah, A.; Aljabali, A.A.A.; Tambuwala, M.M.
Unraveling the Potential of Isorhamnetin as an Adjuvant in Depression Treatment with Escitalopram. Curr. Issues Mol. Biol. 2023, 45, 7668-7679.
https://doi.org/10.3390/cimb45090484
AMA Style
Gammoh O, Qnais EY, Athamneh RY, Al-Jaidi B, Al-Tawalbeh D, Altaber S, Alqudah A, Aljabali AAA, Tambuwala MM.
Unraveling the Potential of Isorhamnetin as an Adjuvant in Depression Treatment with Escitalopram. Current Issues in Molecular Biology. 2023; 45(9):7668-7679.
https://doi.org/10.3390/cimb45090484
Chicago/Turabian Style
Gammoh, Omar, Esam Y. Qnais, Rabaa Y. Athamneh, Bilal Al-Jaidi, Deniz Al-Tawalbeh, Sara Altaber, Abdelrahim Alqudah, Alaa A. A. Aljabali, and Murtaza M. Tambuwala.
2023. "Unraveling the Potential of Isorhamnetin as an Adjuvant in Depression Treatment with Escitalopram" Current Issues in Molecular Biology 45, no. 9: 7668-7679.
https://doi.org/10.3390/cimb45090484
APA Style
Gammoh, O., Qnais, E. Y., Athamneh, R. Y., Al-Jaidi, B., Al-Tawalbeh, D., Altaber, S., Alqudah, A., Aljabali, A. A. A., & Tambuwala, M. M.
(2023). Unraveling the Potential of Isorhamnetin as an Adjuvant in Depression Treatment with Escitalopram. Current Issues in Molecular Biology, 45(9), 7668-7679.
https://doi.org/10.3390/cimb45090484
